This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Folate and Human Development
edited by Edward J. Massaro and John M. Rogers,
359 pp., ill., Totowa, NJ, Humana, 2002, $119
During the decade since the MRC Vitamin Study Research Group definitively reported the effects of folic acid in the prevention of neural tube defects, there has been great interest in determining more about its exact biologic mechanisms. Folate and Human Development is a comprehensive review of this essential B-vitamin and its role in embryology, teratology, and developmental malformations. The editors Massaro and Rogers have assembled detailed synopses by recognized authorities whose diverse expertise ranges from genetics to metabolism to nutrition to teratology to epidemiology. As the title implies, the broad aim of the book is to review the most important research data of folate in human developmental disorders. In general, each contributor meets the book’s objectives by aligning the available data to explain the putative mechanisms for folate’s effects.
The basis of Folate and Human Development revolves around the 1991 MRC neural tube defect prevention study—this remarkable epidemiologic story is probably well known to all potential readers but it appears to still be the driving force behind much of the basic research striving to elucidate the multiple potential functions of folate. The strength of the book lies in its varied perspectives that allow the reader to envision the potential roles of all B vitamins from genes to whole embryos.
The book is divided into 15 parts that cover the most important basic and clinical sciences including the newest research about genomics, the role of folate homeostasis genes, the methylation cycle, folate receptors, embryotoxins, and the interactions of folate with other essential nutrients such as zinc, copper, iron, and choline. Most chapters …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
Hyperhomocysteinemia as an independent risk factor for silent brain infarction
Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation
Clinicopathologic features of folate-deficiency neuropathy
Interaction of serum vitamin B12 and folate with MTHFR genotypes on risk of ischemic stroke